Tetraphase Pharmaceuticals
| Region | Nordamerika |
| ISIN | US88165N1054 |
| Sektor | Biotechnologie |
| Website | https://www.tphase.com/ |
Tetraphase Pharmaceuticals is a clinical-stage life science company with a synthetic chemistry technology platform that has the potential to address the global health crisis caused by antibiotic resistance.
| Titel | Datum |
|---|---|
| ABS Approves MISC and China Offshore's Ammonia FPSO Design | vor 11 Tagen |
| MISC Berhad and China Offshore secure ABS approval in principle for ammonia FPSO concept | vor 11 Tagen |
| MISC and China Offshore's ammonia FPSO design wins ABS' blessing | vor 11 Tagen |
| MISC, China Offshore Secure US Approval For Pioneering Ammonia FPSO Design | vor 11 Tagen |
| Stock Today: MISC Gains 0.41% Amid Offshore Contract Win | vor 17 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Tesla (3 Artikel) | |
| Telit Communications (3 Artikel) | |
| The Naga Group (2 Artikel) | |
| The Priceline Group (2 Artikel) | |
| Alle anzeigen | |